Heart 1998;80:270-275 ( September )
Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection
a Department of
Internal Medicine, Division of Internal Medicine/ Gastroenterology,
School of Medicine, University of Ioannina, 451 10 Greece, b Division of Cardiology, University of Ioannina, c Blood Bank, University Hospital of Ioannina,
Greece
Correspondence to: Professor Tsianos.
Accepted for publication 23 March 1998
Objective
To determine
whether there is an association between hepatitis C virus (HCV)
infection and dilated cardiomyopathy in a well defined area of
north western Greece; such an association has been reported elsewhere.
Design
Evaluation of
consecutive patients with chronic HCV infection for the presence of
clinical or subclinical manifestations of dilated cardiomyopathy by
history, physical examination, and non-invasive laboratory procedures
(ECG, chest x ray, and echocardiography) before the initiation of interferon
treatment; investigation for
HCV infection markers in patients with dilated cardiomyopathy by enzyme
and immunoblot assays (antibodies to HCV) and the reverse transcriptase
polymerase chain reaction (HCV RNA).
Setting
A tertiary
referral centre for patients with chronic hepatitis and dilated cardiomyopathy.
Patients
102 patients
with well defined chronic HCV infection and 55 patients with well
established dilated cardiomyopathy were evaluated.
Main outcome
measures
The need for HCV testing in
patients with dilated cardiomyopathy, or follow up for heart disease in
patients with chronic HCV infection.
Results
None of
the patients with chronic HCV infection had clinical or subclinical
evidence of dilated cardiomyopathy from history and laboratory
findings. None of the patients with dilated cardiomyopathy was positive
for antibodies to HCV or viraemic on HCV RNA testing.
Conclusions
The
study neither confirms the findings of other investigators, nor
indicates a pathogenic link between HCV and dilated cardiomyopathy. For
this reason, at least in Greece, testing for HCV in patients with
dilated cardiomyopathy or follow up for heart disease in HCV patients
appears unnecessary. Genetic or other factors could be the reason for
this discrepancy if previously reported associations between HCV and
dilated cardiomyopathy or hypertrophic cardiomyopathy were not coincidental.
© 1998 by Heart
This article has been cited by other articles:
-
Stefanou, N., Satra, M., Papanikolaou, V., Kalala, F., Gatselis, N., Germenis, A., Dalekos, G. N., Tsezou, A.
(2006). Leptin receptor isoforms mRNA expression in peripheral blood mononuclear cells from patients with chronic viral hepatitis.. Exp. Biol. Med.
231: 1653-1663
[Abstract] [Full Text] -
Germenis, A. E., Yiannaki, E. E., Zachou, K., Roka, V., Barbanis, S., Liaskos, C., Adam, K., Kapsoritakis, A. N., Potamianos, S., Dalekos, G. N.
(2005). Prevalence and Clinical Significance of Immunoglobulin A Antibodies against Tissue Transglutaminase in Patients with Diverse Chronic Liver Diseases. CVI
12: 941-948
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
